Birmingham Psychiatry Pharmaceutical is a clinical research site located in Birmingham, Alabama, United States 35209.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Birmingham Psychiatry Pharmaceutical has participated in 4 clinical trials.
Therapeutic areas: Schizophrenia.
Sponsors: Sumitomo Pharma America, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Birmingham Psychiatry Pharmaceutical has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Birmingham Psychiatry Pharmaceutical has 4 clinical trials on record. Their work covers Schizophrenia.
Birmingham Psychiatry Pharmaceutical has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.